A Decentralized Clinical Trial (DCT) is a study model that leverages technology and remote processes to conduct research outside traditional clinical settings. DCTs allow participants to engage in trials from their homes or local healthcare facilities, reducing the need for frequent visits to centralized study sites.
This approach utilizes digital health technologies, telemedicine, and home health care services to collect data and monitor participants. DCTs aim to improve patient recruitment and retention by offering greater convenience and accessibility, particularly for individuals with mobility issues or those living in remote areas.
Decentralized Clinical Trials (DCTs) are transforming the landscape of clinical research by addressing key challenges in traditional trial methodologies. They offer potential solutions to issues such as slow patient recruitment, high dropout rates, and limited diversity in study populations, which have long hindered the efficiency and representativeness of clinical studies.
The importance of DCTs has been further highlighted by global events like the COVID-19 pandemic, which necessitated alternative approaches to conducting research. By embracing DCTs, the clinical research industry can enhance patient-centricity, improve data quality through continuous monitoring, and potentially accelerate the drug development process, leading to faster delivery of new treatments to patients.
3 Questions with: Prof. Piotr Słomka Large language models are entering nuclear cardiology at a pace that makes the usual…
How Axcellant helped a diagnostic study overcome isotope supply, manufacturing, and logistics constraints In radiopharmaceutical development, we often say that…
Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…
Copyright @ 2026 Axcellant